Source: Pharmabiz

Angelini: Angelini Pharma, JCR Pharma enter global collaboration to develop & commercialize of novel biologic therapies in epilepsy

Angelini Pharma, part of the privately owned Angelini Industries, and JCR Pharmaceuticals Co., Ltd. announced that they entered into an exclusive global development and commercialization agreement for the

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Pierluigi Antonelli's photo - CEO of Angelini

CEO

Pierluigi Antonelli

CEO Approval Rating

50/100

Read more